Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

New York, USA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to...
December 03, 2025 12:51 ET | Source: CrazyBulk

Most Popular Legal Steroids for Muscle Building from CrazyBulk: Legal Steroid Alternatives for Lean Muscle Growth and Cutting in 2026

WASHINGTON DC, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best-Selling Steroid Alternatives for Lean Muscle Growth and Cutting in 2026 ...
November 25, 2025 01:15 ET | Source: Novartis Pharma AG

Novartis data underscore pioneering scientific innovation in hematology and oncology at ASH and SABCS

Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix data across clinical and real-world settings...
November 21, 2025 16:21 ET | Source: AquaSculpt

AquaSculpt Ice Hack Explained: Why Plant-Based Metabolic Support Supplements Are Replacing High-Caffeine Fat Burners—L-Carnitine, Berberine & Chromium Multi-Pathway Approach Addresses FDA Registration Confusion and Safety Concerns

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Industry Analysis: The AquaSculpt ice hack method combining cold water thermogenesis with plant-based metabolic support supplementation has emerged...
November 21, 2025 08:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

– Company to Receive $90 Million Total Payment – – Third Largest Global Market for Cardiovascular Prevention Represents Significant Global Growth Opportunity for NEXLETOL – ANN ARBOR, Mich., Nov. ...
November 19, 2025 08:00 ET | Source: Esperion Therapeutics, Inc.

Esperion to Participate in Piper Sandler 37th Annual Healthcare Conference

ANN ARBOR, Mich., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at the Piper Sandler 37th Annual Healthcare Conference in New York on...
November 19, 2025 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease

Agios today announced topline results from the 52-week double-blind period of the global RISE UP Phase 3 trial
November 18, 2025 07:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

ANN ARBOR, Mich., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that HLS Therapeutics Inc. (TSX: HLS), the Company’s partner in Canada for the development and...
November 17, 2025 10:26 ET | Source: Research and Markets

MRNA Vaccine Raw Materials Market - Global Forecast 2025-2030: Opportunities in Supply Chain Agility and Specialized Component Sourcing

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "mRNA Vaccine Raw Materials Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.This comprehensive analysis...
November 14, 2025 09:00 ET | Source: Reading International Inc

Reading International Reports Third Quarter 2025 Results

Earnings Call Webcast to Discuss Third Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, November 18, 2025 NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Reading...